Is Taro Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Taro Pharmaceutical pays dividends. Last time was Friday 28th of December 2018 where the investors holding the stock on Monday 10th of December 2018 were paid $12.8601 per share. Over the last 1 times between 2018 and 2018, Taro Pharmaceutical has paid $12.8601 with an average of $12.86 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Taro Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $80.24, you would have made a loss of $-37.27 per share or -46.45%
Yes, the average daily trading liquidity for Taro Pharmaceutical is $32 927 thousand. You should therefore be able to get in and out of your positions relatively fast.
Taro Pharmaceutical has no real debt, which is good in periods of high inflation. Taro Pharmaceutical has a good net profit margin of 8.56% and should have high tolerances against inflation.
We have calculated the inflation risk for Taro Pharmaceutical to be low [0.4 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.